Hassan Kadhim Defines Decentralized Clinical Trials | ProofPilot
Interest in decentralized clinical trials (DCTs) is now full steam ahead – and so is the confusion....
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
Clinical research is complex, and rightfully so. What we do is often uncharted and difficult....
GxP compliance is becoming increasingly critical for a patient recruitment capability, and for good...
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
Interest in decentralized clinical trials (DCTs) is now full steam ahead – and so is the confusion....
We know clinical trials are vital for developing new medicines, medical devices, and diagnostic...
I am old enough to remember the days before caller ID when poor souls would simply pick up every...
In Part 1 of this series on Reducing Risk in Decentralized Trials, we covered 7 key issues that...
Since 1999, I have been trying to crack the nut of how to scale physician referrals as a successful...
On a recent Diligent Pharma Webinar, Joseph Kim, Chief Strategy Officer of ProofPilot, covered 7...